107 related articles for article (PubMed ID: 18645267)
1. Value of immediate anastomotic biopsy following biochemical failure after radical prostatectomy.
Anagnostou T; Sofras F; Melekos MD; Pantazopoulos D; Lykourinas M; Giannopoulos A; Djavan B
Urol Int; 2008; 81(1):23-8. PubMed ID: 18645267
[TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
3. Residual benign prostatic glands at the urethrovesical anastomosis after radical retropubic prostatectomy: prediction and impact on disease outcome.
Paul R; Hoppmann M; van Randenborgh H; Kübler H; Alschibaja M; Günther M; Hartung R
Eur Urol; 2004 Sep; 46(3):321-6. PubMed ID: 15306101
[TBL] [Abstract][Full Text] [Related]
4. Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy?
Connolly SS; O'Malley KJ; O'Brien A; Kelly DG; Mulvin DW; Quinlan DM
Scand J Urol Nephrol; 2004; 38(3):216-20. PubMed ID: 15204374
[TBL] [Abstract][Full Text] [Related]
5. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
7. Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?
Anagnostou T; Doumas K; Remzi M; Djavan B
Prostate Cancer Prostatic Dis; 2004; 7(4):302-10. PubMed ID: 15278096
[TBL] [Abstract][Full Text] [Related]
8. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
[TBL] [Abstract][Full Text] [Related]
9. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
[TBL] [Abstract][Full Text] [Related]
10. Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy.
Ozden C; Oztekin CV; Ugurlu O; Gokkaya S; Yaris M; Memis A
Urol Int; 2009; 83(2):146-50. PubMed ID: 19752607
[TBL] [Abstract][Full Text] [Related]
11. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.
Boris RS; Bhandari A; Krane LS; Eun D; Kaul S; Peabody JO
BJU Int; 2009 Apr; 103(7):952-6. PubMed ID: 19076132
[TBL] [Abstract][Full Text] [Related]
12. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival.
Nguyen CT; Reuther AM; Stephenson AJ; Klein EA; Jones JS
J Urol; 2009 Jan; 181(1):75-80. PubMed ID: 19012927
[TBL] [Abstract][Full Text] [Related]
13. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
14. Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer.
Ronquist G; Frithz G; Wang YH; Lindeborg T
Scand J Urol Nephrol; 2009; 43(1):32-6. PubMed ID: 18932051
[TBL] [Abstract][Full Text] [Related]
15. Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?
Godoy G; Tareen BU; Lepor H
Urology; 2009 Jul; 74(1):167-70. PubMed ID: 19406457
[TBL] [Abstract][Full Text] [Related]
16. Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience.
Xylinas E; Drouin SJ; Comperat E; Vaessen C; Renard-Penna R; Misrai V; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Roupret M
BJU Int; 2009 May; 103(9):1173-8; discussion 1178. PubMed ID: 19040530
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic radical prostatectomy after transurethral resection of the prostate: surgical and functional outcomes.
Menard J; de la Taille A; Hoznek A; Allory Y; Vordos D; Yiou R; Abbou CC; Salomon L
Urology; 2008 Sep; 72(3):593-7. PubMed ID: 18762050
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue.
Brimo F; Vollmer RT; Corcos J; Kotar K; Bégin LR; Humphrey PA; Bismar TA
Histopathology; 2008 Aug; 53(2):177-83. PubMed ID: 18752501
[TBL] [Abstract][Full Text] [Related]
19. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
20. Transrectal US in evaluation of patients after radical prostatectomy. Part II. Transrectal US and biopsy findings in the presence of residual and early recurrent prostatic cancer.
Wasserman NF; Kapoor DA; Hildebrandt WC; Zhang G; Born KM; Eppel SM; Reddy PK
Radiology; 1992 Nov; 185(2):367-72. PubMed ID: 1384081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
